Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor  Donata M. Paresce, Richik N. Ghosh, Frederick.

Slides:



Advertisements
Similar presentations
The chemokine CCL2 activates p38 mitogen-activated protein kinase pathway in cultured rat hippocampal cells  Jungsook Cho, Donna L. Gruol  Journal of.
Advertisements

Volume 70, Issue 7, Pages (October 2006)
The Small-Molecule Iron Transport Inhibitor Ferristatin/NSC Promotes Degradation of the Transferrin Receptor  Lior Horonchik, Marianne Wessling-Resnick 
by Martha B. Johnson, and Caroline A. Enns
by Zhengyan Wang, Tina M. Leisner, and Leslie V. Parise
Visualization of ER-to-Golgi Transport in Living Cells Reveals a Sequential Mode of Action for COPII and COPI  Suzie J. Scales, Rainer Pepperkok, Thomas.
A Mechanism for Modulation of Cellular Responses to VEGF
Volume 6, Issue 2, Pages (February 1997)
Richard T. Ethridge, Mark R. Hellmich, Raymond N. DuBois, B.Mark Evers 
Volume 70, Issue 7, Pages (October 2006)
Cdk2 Kinase Is Required for Entry into Mitosis as a Positive Regulator of Cdc2–Cyclin B Kinase Activity  Thomas M Guadagno, John W Newport  Cell  Volume.
Yihan Wang, Michael A. Shia, Thomas G. Christensen, Steven C. Borkan 
Volume 31, Issue 1, Pages (July 2009)
Human mesangial cells express inducible macrophage scavenger receptor
Kinetic Analysis of High Affinity Forms of Interleukin (IL)-13 Receptors: Suppression of IL-13 Binding by IL-2 Receptor γ Chain  Vladimir A. Kuznetsov,
Volume 4, Issue 6, Pages (June 1996)
Volume 2, Issue 6, Pages (December 2007)
Volume 124, Issue 5, Pages (May 2003)
The RecF Protein Antagonizes RecX Function via Direct Interaction
Volume 20, Issue 5, Pages (May 2004)
Volume 16, Issue 22, Pages (November 2006)
Complement Receptor Type 1 (CR1, CD35) Is a Receptor for C1q
Volume 37, Issue 2, Pages (January 2003)
Biofilm Inhibitors that Target Amyloid Proteins
Volume 93, Issue 2, Pages (April 1998)
Volume 27, Issue 1, Pages (July 2007)
Volume 5, Issue 2, Pages (August 1996)
Increased Neutrophil Adherence in Psoriasis: Role of the Human Endothelial Cell Receptor Thy-1 (CD90)  Anne Wetzel, Tino Wetzig, Uwe F. Haustein, Michael.
The Spinal Muscular Atrophy Disease Gene Product, SMN, and Its Associated Protein SIP1 Are in a Complex with Spliceosomal snRNP Proteins  Qing Liu, Utz.
Volume 101, Issue 7, Pages (October 2011)
Complement Receptor Type 1 (CR1, CD35) Is a Receptor for C1q
Secretion of Tau via an Unconventional Non-vesicular Mechanism
Recombinant Scinderin Enhances Exocytosis, an Effect Blocked by Two Scinderin- Derived Actin-Binding Peptides and PIP2  L Zhang, M.G Marcu, K Nau-Staudt,
Volume 119, Issue 1, Pages (July 2000)
Legionella Reveal Dendritic Cell Functions that Facilitate Selection of Antigens for MHC Class II Presentation  Annie L Neild, Craig R Roy  Immunity 
Identification of Small Molecule Inhibitors that Distinguish between Non-Transferrin Bound Iron Uptake and Transferrin-Mediated Iron Transport  Jing Xu.
Volume 15, Issue 6, Pages (December 2001)
Deleted in Colorectal Cancer (DCC) Encodes a Netrin Receptor
Volume 23, Issue 12, Pages (December 2015)
Volume 15, Issue 4, Pages (April 2008)
Volume 6, Issue 6, Pages (June 1997)
Volume 31, Issue 1, Pages (July 2009)
CD46 Is a Cellular Receptor for Human Herpesvirus 6
The Role of Polysialic Acid in Migration of Olfactory Bulb Interneuron Precursors in the Subventricular Zone  Huaiyu Hu, Henry Tomasiewicz, Terry Magnuson,
Volume 6, Issue 3, Pages (September 2004)
Volume 18, Issue 4, Pages (April 1997)
Jean Salamero, Bruno Goud  Journal of Investigative Dermatology 
Integrin Activation by R-ras
Volume 19, Issue 9, Pages (September 2012)
Ca2+ Influx through Distinct Routes Controls Exocytosis and Endocytosis at Drosophila Presynaptic Terminals  Hiroshi Kuromi, Atsuko Honda, Yoshiaki Kidokoro 
Amphiregulin Exosomes Increase Cancer Cell Invasion
Volume 3, Issue 1, Pages (January 2006)
Volume 2, Issue 6, Pages (December 2012)
Ralf Jacob, Hassan Y. Naim  Current Biology 
Coxsackievirus Entry across Epithelial Tight Junctions Requires Occludin and the Small GTPases Rab34 and Rab5  Carolyn B. Coyne, Le Shen, Jerrold R. Turner,
Taeyoon Kim, Jung-Hwa Tao-Cheng, Lee E. Eiden, Y.Peng Loh  Cell 
Expression and Function of the Mannose Receptor CD206 on Epidermal Dendritic Cells in Inflammatory Skin Diseases  Andreas Wollenberg, Tilmann Oppel, Eva-Maria.
Volume 12, Issue 9, Pages (September 2005)
Volume 12, Issue 3, Pages (March 2000)
Volume 93, Issue 2, Pages (April 1998)
Signaling via Mitogen-Activated Protein Kinase Kinase (MEK1) Is Required for Golgi Fragmentation during Mitosis  Usha Acharya, Arrate Mallabiabarrena,
Volume 8, Issue 2, Pages (February 1998)
Yann Leverrier, Anne J. Ridley  Current Biology 
Volume 16, Issue 4, Pages (April 1996)
Volume 11, Issue 13, Pages (July 2001)
Sean P. Cullen, Conor J. Kearney, Danielle M. Clancy, Seamus J. Martin 
The Role of Selective Transport in Neuronal Protein Sorting
Volume 10, Issue 6, Pages (December 2004)
Volume 18, Issue 8, Pages (August 2011)
Ca2+ Influx through Distinct Routes Controls Exocytosis and Endocytosis at Drosophila Presynaptic Terminals  Hiroshi Kuromi, Atsuko Honda, Yoshiaki Kidokoro 
Presentation transcript:

Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor  Donata M. Paresce, Richik N. Ghosh, Frederick R. Maxfield  Neuron  Volume 17, Issue 3, Pages 553-565 (September 1996) DOI: 10.1016/S0896-6273(00)80187-7

Figure 1 Microglia Internalize Cy3-Labeled Aβ Microaggregates into the Same Vesicles as FITC-α2M Cy3-Aβ microaggregates (1 μg/ml final concentration) were formed as described in Experimental Procedures. FITC-labeled α2M was then added to the medium containing Cy3-Aβ microaggregates, and this medium was added to microglia isolated from mixed glial cultures with 12 mM lidocaine. After 10 min at 37°C, the cells were rinsed, fixed, and visualized by fluorescence microscopy for Cy3-Aβ (a) and FITC-α2M (b). White arrows indicate examples of colocalization of the internalized Aβ and α2M. With the selective filter sets used for fluorescence microscopy, there is no detectable crossover of Cy3 into the FITC image, or vice versa. Thus, the extensive overlap of the two labels represents cointernalization of Cy3-Aβ and FITC-α2M into the same endosomes. Using negative stain, electron microscopic observation revealed aggregates ranging up to several microns in diameter (c). Higher magnification of aggregates ([d], corresponding to boxed area in [c]) demonstrated the presence of 10 nm fibrils (black arrows). Scale bars, 10 μm (a and b); 500 nm (c); and 50 nm (d). Neuron 1996 17, 553-565DOI: (10.1016/S0896-6273(00)80187-7)

Figure 2 Microglia Internalize Unlabeled Aβ Microaggregates Microglia were incubated with unlabeled Aβ microaggregates, then processed for immunofluorescence. Two sets of microglial cultures were incubated with Aβ microaggregates (20 μg/ml) at 37°C for 30 min and then fixed. One set of cells was then permeabilized with 0.1% Triton X-100 for 20 min at room temperature, while the other set was incubated in medium 1. Both sets were then processed for immunofluorescence as described in Experimental Procedures. Cells incubated with Aβ microaggregates and permeabilized with 0.1% Triton X-100 are shown in (a), and the unpermeabilized cells are shown in (b). A phase contrast image of the cells shown in (b) is shown in (c). Scale bar, 10 μm. Neuron 1996 17, 553-565DOI: (10.1016/S0896-6273(00)80187-7)

Figure 3 RAP Did Not Block Aβ Uptake Aβ microaggregates (20 μg/ml) were formed as described in Experimental Procedures. Where indicated, RAP (40 μg/ml) was then added to the medium containing Aβ microaggregates. Cells were incubated for 5 min at 37°C in the absence (a) or presence (b) of RAP (40 μg/ml). The cells were then incubated for 30 min with Aβ microaggregates in the absence (a) or presence (b) of RAP. The cells were then rinsed, fixed, and permeabilized. The Aβ was detected by immunofluorescence as described in Experimental Procedures. Scale bar, 20 μm. Neuron 1996 17, 553-565DOI: (10.1016/S0896-6273(00)80187-7)

Figure 4 SR Ligands Block Cy3-Aβ Uptake by Microglia Microglia were incubated for 10 min at 37°C in labeling medium (with 2 mg/ml ovalbumin) with either Cy3-Aβ microaggregates or DiI-Ac–LDL. Where indicated, cells were incubated with competing ligands before and during the addition of the labeled ligands. The cells were then rinsed, fixed, and viewed by fluorescence microscopy. Microglia were incubated with 5 μg/ml DiI-Ac–LDL (a), 5 μg/ml DiI-Ac–LDL + 200 μg/ml Ac–LDL (b), 2 μg/ml Cy3-Aβ (c), 2 μg/ml Cy3-Aβ + 200 μg/ml Ac–LDL (d), 20 μg/ml DiI-Ac–LDL (e), 20 μg/ml DiI-Ac–LDL + 500 μg/ml fucoidan (f), 1 μg/ml Cy3-Aβ (g), and 1 μg/ml Cy3-Aβ + 500 μg/ml fucoidan (h). The cells shown in (a)–(d) are from matched incubations carried out in one experiment, and the cells in (e)–(h) are from a similar matched set in a separate experiment. Scale bar, 10 μm. Neuron 1996 17, 553-565DOI: (10.1016/S0896-6273(00)80187-7)

Figure 7 Excess Ac–LDL and Fucoidan Competitively Inhibit Uptake of Both Unlabeled and Cy3-Labeled Aβ Microaggregates But Do Not Block Tf Uptake by Microglia We performed a quantitative analysis of the competitive binding experiments shown in Figure 4 and Figure 6 as described in Experimental Procedures. Fluorescence power was determined for at least 20 cells per field in ten fields per condition. The data shown are mean values ± SEM from a representative experiment. The values shown are normalized against the condition with the highest fluorescence per cell. Microglia were incubated with unlabeled Aβ microaggregates (20 μg/ml) alone or in the presence of fucoidan (500 μg/ml) or Ac–LDL (50 μg/ml). Microglia were also incubated with Cy3 Aβ microaggregates (10 μg/ml), or with both Cy3 Aβ microaggregates and Ac–LDL (200 μg/ml). All of the competitors caused a significant reduction in fluorescence power (p < 0.001) by t test. To confirm that inhibition of uptake of Aβ by Ac–LDL was specific, microglia were incubated with Cy3-labeled Tf (20 μg/ml) or Cy3 Aβ in the presence or absence of 200 μg/ml Ac–LDL. Columns are from left to right: microglia incubated with 20 μg/ml unlabeled Aβ microaggregates alone (cntrl), Aβ microaggregates and 500 μg/ml fucoidan (Fc), Aβ microaggregates and 50 μg/ml Ac–LDL (Ac–LDL); 10 μg/ml Cy3 Aβ microaggregates, Cy3 Aβ microaggregates with 200 μg/ml Ac–LDL (Ac–LDL); 20 μg/ml Cy3 Tf, and Cy3 Tf with 200 μg/ml Ac–LDL. Error bars give the SEM. Neuron 1996 17, 553-565DOI: (10.1016/S0896-6273(00)80187-7)

Figure 6 Excess Ac–LDL and Fucoidan Competitively Inhibit Uptake of Unlabeled Aβ Microaggregates Microglia (isolated with 12 mM lidocaine) were preincubated in labeling medium for 15 min at 37°C with either 1 mg/ml BSA (a), 500 μg/ml fucoidan (b), 50 μg/ml Ac–LDL (c), or 500 μg/ml Ac–LDL (d). The cells were then incubated for a further 30 min with unlabeled Aβ microaggregates with the same additions as in the preincubation. The cultures were then rinsed, fixed, and permeabilized, and the Aβ microaggregates were detected by immunofluorescence. Each of the competing ligands effectively blocked uptake of Aβ microaggregates. Scale bar, 20 μm. Neuron 1996 17, 553-565DOI: (10.1016/S0896-6273(00)80187-7)

Figure 5 Binding of 125I-Labeled Aβ Microaggregates by Microglia Is Inhibited by Excess Ac–LDL, Fucoidan, or M-BSA Microglia were incubated for 2 hr at 37°C with labeling medium (DMEM containing 10 mg/ml BSA) and 1 μg/ml 125I-labeled Aβ microaggregates alone or with medium containing both Aβ microaggregates and 10 μg/ml either Ac–LDL, M-BSA, or fucoidan. After the incubations, unbound ligand was removed with three washes of labeling medium. The cells were chased for 30 min, then rinsed again, solubilized, and cell-associated 125I-labeled Aβ was measured. A background of 125I-labeled Aβ sticking to wells with no cells was subtracted from the total counts (which was less than 10% of control binding). The data shown are an average of the radioactivity in three wells per condition from a representative experiment. Error bars show SEM. Neuron 1996 17, 553-565DOI: (10.1016/S0896-6273(00)80187-7)

Figure 8 125I-Labeled Aβ Microaggregates Are Bound and Taken Up by CHO Cells Transfected with Either the Murine Class A or the Hamster Class B SR (a) CHO cells were incubated for 2 hr at 37°C with labeling medium with 1 μg/ml 125I-labeled Aβ microaggregates alone or with medium containing both Aβ microaggregates and 10 μg/ml either Ac–LDL, M-BSA, or fucoidan. After the incubations, unbound ligand was removed with three washes of labeling medium. The cells were chased for 30 min, solubilized with 1 N NaOH, and cell-associated 125I-labeled Aβ was measured. From left to right: CHO parental cell line incubated with 1 μg/ml 125I-labeled Aβ microaggregates; CHO cells transfected with mSRA-I incubated with 1 μg/ml 125I-labeled Aβ microaggregates alone or with 10 μg/ml Ac–LDL, fucoidan, or M-BSA; CHO cells transfected with mSRA-II incubated with 1 μg/ml 125I-labeled Aβ microaggregates and these same inhibitors; CHO cells transfected with haSRA-B1 incubated with the same inhibitors; ldlA7 parental cell line incubated with 1 μg/ml 125I-labeled Aβ microaggregates. (b) For Tf uptake, TRVb1 cells were incubated with 125I- Tf in iron-poor medium (McCoy's 5A medium) for 30 min, rinsed six times with incubation medium, and solubilized with 1 N NaOH. Cell associated 125I-labeled Tf was counted. The incubation medium contained either 125I-labeled Tf (1 μg/ml) alone or with 200 μg/ml of unlabeled diferric Tf, Ac–LDL, fucoidan, or M-BSA. The data presented are averages of the radioactive counts from three dishes per condition from a representative experiment. Error bars give the SEM. Neuron 1996 17, 553-565DOI: (10.1016/S0896-6273(00)80187-7)

Figure 8 125I-Labeled Aβ Microaggregates Are Bound and Taken Up by CHO Cells Transfected with Either the Murine Class A or the Hamster Class B SR (a) CHO cells were incubated for 2 hr at 37°C with labeling medium with 1 μg/ml 125I-labeled Aβ microaggregates alone or with medium containing both Aβ microaggregates and 10 μg/ml either Ac–LDL, M-BSA, or fucoidan. After the incubations, unbound ligand was removed with three washes of labeling medium. The cells were chased for 30 min, solubilized with 1 N NaOH, and cell-associated 125I-labeled Aβ was measured. From left to right: CHO parental cell line incubated with 1 μg/ml 125I-labeled Aβ microaggregates; CHO cells transfected with mSRA-I incubated with 1 μg/ml 125I-labeled Aβ microaggregates alone or with 10 μg/ml Ac–LDL, fucoidan, or M-BSA; CHO cells transfected with mSRA-II incubated with 1 μg/ml 125I-labeled Aβ microaggregates and these same inhibitors; CHO cells transfected with haSRA-B1 incubated with the same inhibitors; ldlA7 parental cell line incubated with 1 μg/ml 125I-labeled Aβ microaggregates. (b) For Tf uptake, TRVb1 cells were incubated with 125I- Tf in iron-poor medium (McCoy's 5A medium) for 30 min, rinsed six times with incubation medium, and solubilized with 1 N NaOH. Cell associated 125I-labeled Tf was counted. The incubation medium contained either 125I-labeled Tf (1 μg/ml) alone or with 200 μg/ml of unlabeled diferric Tf, Ac–LDL, fucoidan, or M-BSA. The data presented are averages of the radioactive counts from three dishes per condition from a representative experiment. Error bars give the SEM. Neuron 1996 17, 553-565DOI: (10.1016/S0896-6273(00)80187-7)

Figure 9 Unlabeled Aβ Microaggregates Block DiI-Ac–LDL Uptake Aβ microaggregates were prepared at concentrations from 50–500 μg/ml. Ac–LDL was diluted to a concentration of 100 μg/ml. Microglia were incubated for 30 min at 37°C with labeling medium containing either Ac–LDL (b), Aβ microaggregates (c–d) or BSA (a). DiI-Ac–LDL at a concentration of 1 μg/ml was then added to each of the different media and the cells were incubated for an additional 10 min. The cells were then rinsed, fixed, and viewed by fluorescence microscopy. Bar, 20 μm. (a) DiI-Ac–LDL + BSA. (b) DiI-Ac–LDL + 100 μg/ml Ac–LDL. (c) DiI-Ac–LDL + 100 μg/ml Aβ. (d) DiI-Ac–LDL + 500 μg/ml Aβ. Neuron 1996 17, 553-565DOI: (10.1016/S0896-6273(00)80187-7)